BioLife Solutions Inc.
BLFS | NASDAQ
$38.07
+$0.89 (+2.39%)
Sep 22, 2026, 1:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 96.21M | 82.25M | 75.86M | 76.24M | 119.16M | 48.09M |
Cost of Revenue | 34.1M | 28.58M | 96.52M | 29.33M | 90.31M | 20.65M |
Gross Profit | 62.12M | 53.67M | 46.75M | 46.91M | 28.85M | 27.44M |
Operating Income | -1.08M | -7.13M | -23.44M | -5.92M | -35.16M | -3.33M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 58K |
Pretax Income | -12.08M | -11.43M | -18.47M | -4.85M | -29.03M | -1.28M |
Net Income | -12.13M | -20.18M | -66.43M | -139.81M | -8.91M | 2.67M |
Selling & General & Admin | 55.37M | 50.15M | 55.97M | 44.93M | 48.09M | 21.02M |
Research & Development | 7.57M | 7.91M | 18.8M | 14.8M | 11.82M | 6.72M |
Other Expenses | n/a | 2.74M | 42.81M | -6.89M | 13.43M | 3.03M |
Operating Expenses | 62.94M | 60.8M | 117.58M | 52.83M | 73.34M | 30.77M |
Interest Expense | 2.71M | 719K | 1.81M | 687K | 485K | 18K |
Selling & Marketing Expenses | 9.85M | 9.61M | 12.71M | 11.67M | 14M | 6.41M |
Cost & Expenses | 97.3M | 89.38M | 99.3M | 82.16M | 154.32M | 54.33M |
Income Tax Expense | 49K | -38K | 24K | -5.24M | -20.12M | -3.26M |
Shares Outstanding (Basic) | 47.75M | 46.07M | 43.72M | 42.48M | 38.5M | 27.31M |
Shares Outstanding (Diluted) | 48.65M | 46.07M | 43.72M | 42.48M | 38.5M | 27.31M |
EPS (Basic) | -0.25 | -0.44 | -1.52 | -3.29 | -0.23 | 0.07 |
EPS (Diluted) | -0.25 | -0.44 | -1.52 | -3.29 | -0.23 | -0.06 |
EBITDA | 3.61M | 1.53M | -45.24M | -124.18M | -16.65M | 1.48M |
EBIT | -1.08M | -7.13M | -25.63M | -10.68M | -30.65M | -3.59M |
Depreciation & Amortization | 4.69M | 8.66M | 12.3M | 19.96M | 12.87M | 5.07M |
Add to Watchlist
Select watchlists to add or remove BLFS